No Data
No Data
GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing
GeneDx Holdings Corp. (NASDAQ:WGS) has made the biggest gains on the Russell 2000 Index in 2024 as the biotechnology company moves toward more comprehensive genetic testing.The Maryland-based company'
UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were mostly higher, with the Dow Jones index gaining around 550 points on Tuesday.Shares of UnitedHealth Group Incorporated (NYSE:UNH) rose sharply during Tuesday's session following a
We Think Janux Therapeutics (NASDAQ:JANX) Can Afford To Drive Business Growth
There's no doubt that money can be made by owning shares of unprofitable businesses. By way of example, Janux Therapeutics (NASDAQ:JANX) has seen its share price rise 241% over the last year, deligh
Small-cap, Buy-rated Stocks With Positive Estimate Revision Factors - BofA
Janux Therapeutics Insider Sold Shares Worth $82,125,000, According to a Recent SEC Filing
Jay Lichter, 10% Owner, Director, on June 03, 2024, sold 1,500,000 shares in Janux Therapeutics (JANX) for $82,125,000. Following the Form 4 filing with the SEC, Lichter has control over a total of 3,
Janux Therapeutics(JANX.US) Officer Sells US$45.04 Million in Common Stock
$Janux Therapeutics(JANX.US)$ Officer Reardon Tighe sold 822.72K shares of common stock on Jun 3, 2024 at an average price of $54.75 for a total value of $45.04 million.Source: Announcement What is st